Immunogenicity in mice of varicella-zoster virus glycoprotein I expressed by a vaccinia virus-varicella-zoster virus recombinant Free

Abstract

Several vaccinia virus (VV)-varicella-zoster virus (VZV) recombinants expressing glycoprotein I (gpI) of VZV were isolated from the Prague strain of VV. One of these, v46, was inoculated intraperitoneally into mice. Groups of mice were bled 4 and 8 weeks later and their sera were examined for anti-VZV and anti-VV antibodies by ELISA. At 4 weeks, all mice inoculated with the three largest virus doses (10, 10 and 10 p.f.u.), and at 8 weeks all mice inoculated with the four highest virus doses (10, 10, 10 and 10 p.f.u.), had developed both anti-VV and anti-VZV antibodies. Antibodies were also detected in a high proportion of mice infected with lower doses of virus and in some instances VZV antibodies were present in the absence of VV antibodies. None of the animals inoculated in parallel with either a thymidine kinase-negative mutant of the original VV or diluent alone developed antibody reactive with VZV. The specificity of the reaction was assessed further by Western blotting using anti-gpI monoclonal antibodies as a positive control. Sera from animals immunized with v46 possessed antibody capable of neutralizing extracellular VZV in the presence of complement.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-72-6-1445
1991-06-01
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jgv/72/6/JV0720061445.html?itemId=/content/journal/jgv/10.1099/0022-1317-72-6-1445&mimeType=html&fmt=ahah

References

  1. Arvin A. M., Kinney-Thomas E., Shriver K., Grose C., Koropchak C., Scranton E., Witek A. E., Diaz P. S. 1986; Immunity to varicella-zoster viral glycoproteins, gpI (gp90/58) and gpIII (gp 118), and to a nonglycolysated protein, pl70. Journal of Immunology 137:134–1351
    [Google Scholar]
  2. Brunell P. A., Novelli V. M., Keller P. M., Ellis R. W. 1987; Antibodies to the three major glycoproteins of varicella-zoster virus: search for the relevant host immune response. Journal of Infectious Diseases 156:430–435
    [Google Scholar]
  3. Cabirac G., Gilden D., Wellish M., Vafai A. 1988; Expression of varicella-zoster virus glycoprotein I in cells infected with a vaccinia virus recombinant. Virus Research 10:205–213
    [Google Scholar]
  4. Davison A. J. 1983; DNA sequence of the US component of the varicella-zoster virus genome. EMBO Journal 2:2203–2209
    [Google Scholar]
  5. Davison A. J., Scott J. E. 1986; The complete DNA sequence of varicella-zoster virus. Journal of General Virology 67:1759–1816
    [Google Scholar]
  6. Diaz P. S., Smith S., Hunter E., Arvin A. M. 1988; Immunity to whole varicella-zoster virus antigen and glycoproteins I and pi70: relation to the immunizing regimen of live attenuated varicella vaccine. Journal of Infectious Diseases 158:1245–1252
    [Google Scholar]
  7. Dubey L., Steinberg S. P., La Russa P., Oh P., Gershon A. 1988; Western blot analysis of antibody to varicella-zoster virus. Journal of Infectious Diseases 157:882–888
    [Google Scholar]
  8. Ecker J. R., Hyman R. W. 1982; Varicella-zoster virus DNA exists as two isomers. Proceedings of the National Academy of Sciences, U.S.A. 79:156–160
    [Google Scholar]
  9. Grose C. 1989; Congenital varicella-zoster infection and the failure to establish virus-specific cell-mediated immunity. Molecular Biology and Medicine 6:453–462
    [Google Scholar]
  10. Grose C., Litwin V. 1988; Immunology of the varicella-zoster virus. Journal of Infectious Diseases 157:877–881
    [Google Scholar]
  11. Ilobi C. P., Martin A. B. 1989; A simple and sensitive assay for varicella-zoster virus. Journal of Virological Methods 23:137–148
    [Google Scholar]
  12. Joklik W. K. 1962; The purification of four strains of poxvirus. Virology 18:9–18
    [Google Scholar]
  13. Keller P. M., Neff B. J., Ellis R. W. 1984; Three major glycoprotein genes of varicella-zoster virus whose products have neutralization epitopes. Journal of Virology 52:293–297
    [Google Scholar]
  14. Kutinová L., Nmečková S., Hamšíková E., Press M., Závadová H., Hirsch I., Nmeček V., Krchňák V., Smrt J., Slonim D., Vonka V. 1990; A recombinant vaccinia virus expressing hepatitis B virus middle surface protein: restricted expression of HBV antigens in human diploid cells. Archives of Virology 112:181–193
    [Google Scholar]
  15. Montalvo E. A., Grose C. 1986; Varicella-zoster virus glycoprotein gpl is selectively phosphorylated by a virus-induced protein kinase. Proceedings of the National Academy of Sciences, U,. S,. A 83:8967–8971
    [Google Scholar]
  16. Slonim D., Hulenová M. 1969; Study of plaque titration of vaccinia virus in chick embryo cell cultures. I. Assays under an agar overlay. Acta virologica 13:209–215
    [Google Scholar]
  17. Slonim D., Kratochvílová M. 1978; Smallpox vaccine. 4. Relative infectious activity for man. Československa Epidemiologic, Mikrobiologie, Imunologie 27:206–211
    [Google Scholar]
  18. Soike K. F., Keller P. M., Ellis R. W. 1987; Immunization of monkeys with varicella-zoster virus glycoprotein antigens and their response to challenge with simian varicella virus. Journal of Medical Virology 22:307–313
    [Google Scholar]
  19. Vafai A., Jensen K., Kubo R. 1989; Existence of similar antigenic sites on varicella-zoster virus gpl and gpIV. Virus Research 13:319–336
    [Google Scholar]
  20. Vafai A., Wroblewska Z., Mahalingam R., Cabirac G., Wellish M., Cisco M., Gilden D. 1988; Recognition of similar epitopes on varicella-zoster virus gpl and gpIV by mono clonal antibodies. Journal of Virology 62:2544–2551
    [Google Scholar]
  21. Vafai A., Jensen K., Kubo R. 1989; Existence of similar antigenic sites on varicella-zoster virus gpl and gpIV. Virus Research 13:319–336
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-72-6-1445
Loading
/content/journal/jgv/10.1099/0022-1317-72-6-1445
Loading

Data & Media loading...

Most cited Most Cited RSS feed